Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment

Journal of Cellular Physiology

Volumn 166, Issue 2, 1996, Pages 370-379

  Hakeda, Yoshiyukl ^a,b   Kawaguchi, Hiroshi ^a   Hurley, Marja ^a   Pilbeam, Carol C ^a   Abreu, Christine ^a   Linkhart, Thomas A ^c   Mohan, Subburaman ^c   Kumegawa, Masayoshi ^b   Raisz, Lawrence G ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PROSTAGLANDIN E2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MATRIX; BONE METABOLISM; CALVARIA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; MOUSE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS;

ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; BONE MATRIX; CULTURE MEDIA, CONDITIONED; CULTURE TECHNIQUES; DINOPROSTONE; ENDOPEPTIDASES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MICE; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SKULL; SOLUBILITY;

ANIMALIA;

EID: 0030071130     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199602)166:2<370::AID-JCP15>3.0.CO;2-F     Document Type: Article

References (59)

1. Andres, J.L., Stanley, K., Cheifetz, S., and Massague, J. (1989) Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β. J. Cell Biol., 109:3137-3145.
2. Andress, D.L., and Birnbaum, R.S. (1991) A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells. Biochem. Biophys. Res. Commun., 176:213-218.
3. Andress, D.L., and Birnbaum, R.S. (1992) Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem., 267:22467-22472.
4. Andress, D.L., Loop, S.M., Zapf, J., and Kiefer, M.C. (1993) Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem. Biophys. Res. Commun., 195:25-30.
5. Arai, T., Arai, A., Busby, W. H. Jr., and Clemmons, D.E. (1994) Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5. Endocrinology, 135:2358-2363.
6. Bautista, C., Mohan, S., and Baylink, D.J. (1990) Insulin-like growth factors I and II are present in the skeletal tissues often vertebrates. Metabolism 33:96-100.
7. Bautista, C.M., Baylink, D.J., and Mohan, S. (1991) Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential condidate for fixing IGF-II in human bone. Biochem. Biophys. Res. Commun., 176:756-763.
8. Camacho-Hubner, C., Busby, W.H., McCusker, R.H.Jr., Wright, G., and Clemmons, D.R. (1992) Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J. Biol. Chem., 267:11949-11956.
9. 3 modulation of insulin-like growth factor binding proteins in rat osteoblast-like cell cultures. Endocrinology, 128:73-80.
10. Chen, T.L., Liu, F., Bates, R.L., and Hintz, R.L. (1991) Further characterization of insulin-like growth factor binding proteins in rat osteoblast-like cell cultures: Modulation by 17β-estradiol and human growth hormone. Endocrinology, 128:2489-2496.
11. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159.
12. Clemmons, D.R. (1991) Insulin-like growth factor binding proteins: Roles in regulating IGF physiology. J. Dev. Physiol., 15:105-110.
13. Conover, C.A., and Kiefer, M.C. (1993) Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 inhuman osteoblastic cells. J. Clin. Endocrinol. Metab., 76:1153-1159.
14. Conover, C.A., Bale, L.K., Clarkson, J.T., and Totting, O. (1993a) Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells. Endocrinology, 132:2525-2530.
15. Conover, C.A., Kiefer, M.C., and Zapf, J. (1993b) Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts: Insulin-like growth factor dependence and biological studies. J. Clin. Invest., 97:1129-1137.
16. Ernst, M., and Rodan, G.A. (1990) Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): Positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology, 127:807-814.
17. Ernst, M., Heath, J.K., and Rodan, G.A. (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology, 125:825-833.
18. 281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae. J. Biol. Chem., 266:19469-19474.
19. 2 stimulates DNA synthesis by a cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells. J. Cell. Physiol., 128:155-161.
20. 2α stimulates proliferation of clonal osteoblastic MC3T3-E1 cells by up-regulation of insulin-like growth factor I receptors. J. Biol. Chem., 266:21044-21050.
21. Hill, D.J., Camacho-Hubner, C., Rashid, P., Strain, A.J., and Clemmons, D.R. (1989) Insulin-like growth factor (IGF)-binding protein release by human fetal fibroblasts: Dependency on cell density and IGF peptides. J. Endocrinol., 122:87-98.
22. Hock, J.M., and Gera, I. (1992) Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J. Bone Miner. Res., 7:65-72.
23. Hock, J.M., Centrella, M., and Canalis, E. (1988) Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology, 122:254-260.
24. Hossenlopp, P., Seurin, D., Segovia-Qinson, B., Haudouin, S., and Binoux, M. (1986) Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem., 154:138-143.
25. Jones, J.I., Gockerman, A., Busby, W.H., Camacho-Hubner, C., and Clemmons, D.R. (1993) Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I. J. Cell Biol., 121:679-687.
26. Kanzaki, S., Hilliker, S., Baylink, D.J., and Mohan, S. (1994) Evidence for differential regulation of IGF binding protein (IGFBP)-4 and -5 proleolysis by IGF-II in human bone cells (HBCs). Endocrinology, 134:383-392.
27. Kiefer, M.C., Stephans, J.C., Crawford, K., Okino, K., and Barr, P.J (1990) Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. Proc. Natl. Acad. Sci. U.S.A., 87:6985-6989.
28. Kiefer, M.C., Schmid, C., Waldvogel, M., Schlapfer, I., Futo, E., Masiarz, F.R., Green, K., Barr, P.J., and Zapf, J. (1992) Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J. Biol. Chem., 267:12692-12699.
29. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680-685.
30. LaTour, D., Mohan, S., Linkhart, T.A., Baylink, D.J., and Strong, D.D. (1990) Inhibitory insulin-like growth factor-binding protein: Cloning, complete sequence, and physiological regulation. Mol. Endocrinol., 4:1806-1814.
31. Lauritzen, D.B., Balena, R., Shea, M., Seedor, J.G., Markatos, A., Le, H.M., Toolan, B.C., Myers, E.R., Rodan, G.A., and Hayes, W.C. (1993) Effects of combinated prostaglandin and alendronate treatment on the histomorphometry and biochemical properties of bone in overiectomized rats. J. Bone Miner. Res., 8:871-879.
32. Linkhart, T.A., and Mohan, S. (1989) Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology, 125:1484-1491.
33. Lyons, R.M., Gentry, L.E., Purchio, A.F., and Moses, H.L. (1990) Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J. Cell Biol., 110:1361-1367.
34. McCarthy, T.L., Centrella, M., and Canalis, E. (1989a) Regulatory effects of insulin-like growth factor I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology, 124:301-309.
35. McCarthy, T.L., Centrella, M., and Canalis, E. (1989b) Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology, 124:1247-1253.
36. 2, growth hormone, and the insulin-like growth factors. J. Cell. Physiol., 160:163-175.
37. Mohan, S , Jennings, J.C., Linkhart, T.A., and Baylink, D.J. (1988) Primary structure of human skeletal growth factor: Homology with human insulin like growth factor II. Biochim. Biophys. Acta, 966:44-55.
38. Mohan, S., Bautista, C.M., Wergedal, J., and Baylink, D.J. (1989) Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action. Proc. Natl. Acad. Sci. U.S.A., 86:8338-8342.
39. Mohan, S., Libanati, C., Dony, C., Lang, K., Srinivasan, N., and Baylink, D.J. (1995) Development, validation and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J. Clin. Endocrinol. Metab., 80:2638-2645.
40. Parker, A., Gockerman, A., Busby, W.H., and Clemmons, D.E. (1995) Properties of an insulin-like growth factor-binding protein-4 that is secreted by smooth muscle cells. Endocrinology, 136:2470-2476.
41. Pfeilschifter, J., and Mundy, G.R. (1987) Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. U.S.A., 84:2024-2028.
42. Pfeilschifter, J., Oechsner, M., Naumann, A., Gronwald, R.A.K., Minne, H.W., and Ziegler, R. (1990) Stimulation of bone matrix apposition in vitro by local growth factors: A comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor. Endocrinology, 127:69-75.
43. Podbesek, R., Edouard, C., Meunier, P.J., Parsons, J.A., Reeve, J., Stevenson, R W., and Zanelli, J. (1983) Effects of two treatment regimes with synthetic human parathyroid hormone fragments on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology, 112:1000-1006.
44. 2 on bone formation in cultured fetal rat calvariae: Interaction with cortisol. Endocrinology, 126:1654-1659.
45. 2 production. Endocrinology, 126:1076-1079.
46. 2 on bone formation in cultured fetal rat calvariae: Role of insulin-like growth factor-I. Endocrinology, 133:1504-1510.
47. 3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology, 123:3139-3146.
48. Schmid, C., Guler, H., Rowe, D., and Froesch, E.R. (1989a) Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats. Endocrinology, 125:1575-1580.
49. Schmid, C., Zapf, J., and Froesch, E.R. (1989b) Production of carrier proteins of insulin-like growth factors (IGFs) by rat osteoblastic cells. FEBS Lett., 244:328-332.
50. 3) stimulates insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro. Acta Endocrinol., 126:467-473.
51. 2 stimulates synthesis of insulin-like growth factor binding protein-3 in rat bone cells in vitro. J. Bone Miner. Res., 7:1157-1163.
52. Schmid, C., Schlapfer, I., Peter, M., Boni-Schnetzler, M., Schwander, J., Zapf, J., and Froesch, E.R. (1994) Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. Am. J. Physiol., 267:E226-E233.
53. Shimasaki, S., and Ling, N. (1991) Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res., 3:243-266.
54. Shimasaki, S., Gao, L., Shimonaka, M., and Ling, N. (1991a) Isolation and molecular cloning of insulin-like growth factor-binding protein-6. Mol. Endocrinol., 5:938-948.
55. Shimasaki, S., Shimanaka, M., Zhang, H., and Ling, N. (1991b) Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J. Biol. Chem., 266:10646-10653.
56. Slovik, D.M., Neer, R.M., and Potts, J.T. Jr. (1981) Short term effects of synthetic human parathyroid hormone-(1-34) administration on bone mineral metabolism in osteoporotic patients. J. Clin. Invest., 68:1261-1271.
57. Toning, O., Firek, A.F., Heath, H. III, and Conover, C.A. (1991) Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-Uke cells through a adenosine 3′,5′-monophosphate-dependent mechanism. Endocrinology, 128:1006-1014.
58. Vernillo, A.T. (1992) Parathyroid hormone regulation of matrix degrading enzymes in rat osteoblastic osteosarcoma 17/2.8 cells. Res. Commun. Chem. Pathol. Pharmacol., 75:323-339, 1992.
59. Yamaguchi, Y., Mann, D.M., and Ruoslahti, E. (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature, 346:281-284.